,4 In CRC, the methylation levels of specific genes may serve as cancer biomarkers; for example, methylation-specific assays have been developed to detect cancer-derived SEPT9 and VIM1 DNA in blood and fecal samples, respectively.5 This evidence concerns the gene SEPTIN9 and colorectal carcinoma.